Susumu Kitagawa Japanese chemist Susumu Kitagawa at a press conference after winning a share of the 2025 Nobel Prize for Chemistry. (more) Susumu Kitagawa Japanese chemist Ask the Chatbot a Question More Actions Share Share Share to social media Facebook X URL https://www.britannica.com/biography/Susumu-Kitagawa Feedback Corrections? Updates? Omissions? Let us know if you have suggestions to improve this article (requires login). Feedback Type Select a type (Required) Factual Correction Spelling/Grammar Correction Link Correction Additional Information Other Your Feedback Submit Feedback Thank you for your feedback Our editors will review what you’ve submitted and determine whether to revise the article.

　　External Websites Ask the Chatbot a Question Written by Written by Kara Rogers Kara Rogers is the senior editor of biomedical sciences at Encyclopædia Britannica, where she oversees a range of content from medicine and genetics to microorganisms. She joined Britannica in 2006 and... Kara Rogers Fact-checked by Fact-checked by The Editors of Encyclopaedia Britannica Encyclopaedia Britannica's editors oversee subject areas in which they have extensive knowledge, whether from years of experience gained by working on that content or via study for an advanced degree.... The Editors of Encyclopaedia Britannica Last Updated: Oct. 8, 2025 •Article History Table of Contents Table of Contents Ask the Chatbot Susumu Kitagawa (born July 4, 1951, Kyōto, Japan) is a Japanese chemist who is known for developing metal-organic frameworks (MOFs), a class of highly porous materials created by coordinating metal ions with organic linkers. Because of their high degree of porosity, these advanced crystalline materials have vast surface areas that enable high-efficiency gas capture and storage, which have fueled advances in gas-adsorption technologies. For his contributions to the development of MOFs, Kitagawa was awarded the...

　　Continue reading with Britannica Premium The trusted destination for facts and information 7-Day Free Trial, No Ads, Unlimited Access Subscribe Today